CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1...
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals
About this item
Full title
Author / Creator
Ahuja, Sunil K , Kulkarni, Hemant , Catano, Gabriel , Agan, Brian K , Camargo, Jose F , He, Weijing , O'Connell, Robert J , Marconi, Vincent C , Delmar, Judith , Eron, Joseph , Clark, Robert A , Frost, Simon , Martin, Jeffrey , Ahuja, Seema S , Deeks, Steven G , Little, Susan , Richman, Douglas , Hecht, Frederick M and Dolan, Matthew J
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
The basis for the extensive variability seen in the reconstitution of CD4
+
T cell counts in HIV-infected individuals receiving highly active antiretroviral therapy (HAART) is not fully known. Here, we show that variations in
CCL3L1
gene dose and
CCR5
genotype, but not major histocompatibility complex HLA alleles, influence immune...
Alternative Titles
Full title
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2630879
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2630879
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/nm1741
